Back to results
US 4,379,785 AGranted
Heterocyclic substituted sulfonyl ureas, and their use
AssigneeHoechst Aktiengesellschaft
InventorsRudi Weyer, Volker Hitzel, Karl Geisen, Gunter Regitz
Life of this patent
Estimating the term…
Abstract
What are disclosed are sulfonyl ureas of the formula ##STR1## in which R.sup.1, X and Y are as defined in the specification, and their physiologically acceptable salts, pharmaceutical formulations on the basis of these compounds, and their use in the treatment of diabetes.
Claims6
A sulfonyl urea of the formula ##STR12## or a physiologically acceptable salt thereof, wherein X is alkylene or alkenylene having from 3 to 6 carbon atoms, optionally substituted by up to 3 alkyl groups each having from 1 to 4 carbon atoms, or by phenyl;
- or the group ##STR13## is a bicyclic system of the formula ##STR14## and Y is alkylene having 2 or 3 carbon atoms;
- R.sup.1 is alkyl having from 4 to 6 carbon atoms, cycloalkyl, alkylcycloalkyl, dialkylcycloalkyl, cycloalkylalkyl, cycloalkenyl, or alkylcycloalkenyl in each case having 4 to 9 carbon atoms, or is methylcyclopentylmethyl, cyclohexenylmethyl, chlorocyclohexyl, methoxycyclohexyl, bicycloheptyl, bicycloheptenyl, bicycloheptylmethyl, bicycloheptenylmethyl, bicyclooctyl, nortricyclyl, adamantyl, or benzyl.
Dependencies are inferred from the claim text.